Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Feb;37(1):85-87.
doi: 10.3341/kjo.2022.0105. Epub 2022 Oct 25.

Corneal Graft Rejection after Vaccination against COVID-19: A Case Report

Ji Min Park  1 , Jee Hye Lee  1 , Je Hyung Hwang  1 , Min-Ji Kang  1
Affiliations
Case Reports

Corneal Graft Rejection after Vaccination against COVID-19: A Case Report

Ji Min Park et al. Korean J Ophthalmol. 2023 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None.

Figures

Fig. 1
Fig. 1
Change in slit-lamp image and corneal endothelial cell count. (A) Slit-lamp image of a clear grafted cornea at the last follow-up before vaccination for several SARS-CoV-2. (B) Slit-lamp image at presentation on day 7 after vaccination with slight conjunctival injection and mild corneal edema. (C) Fine keratic precipitates found in the central cornea. (D) The corneal endothelial cell count was 1,320 cells/mm2 at the last visit before coronavirus disease vaccination. (E) Corneal endothelial cells were unmeasurable in numeric value, but the cell count, hexagonality, and size variation had increased 7 days after vaccination. (F) After treatment with topical and systemic steroids, the corneal endothelial cell count decreased to 1,086 cells/mm2. CCT = central corneal thickness; CD = cell density; CV = coefficient of variation; HEX = hexagonality; N = number of cells analyzed; MIN = minimum; MAX = maximum; AVG = average; SD = standard deviation; N/A = not available.
See this image and copyright information in PMC

Comment on

References

    1. Phylactou M, Li JO, Larkin DF. Characteristics of endothelial corneal transplant rejection following immunisation with SARS-CoV-2 messenger RNA vaccine. Br J Ophthalmol. 2021;105:893–6. - PubMed
    1. Wasser LM, Roditi E, Zadok D, et al. Keratoplasty rejection after the BNT162b2 messenger RNA vaccine. Cornea. 2021;40:1070–2. - PMC - PubMed
    1. Abousy M, Bohm K, Prescott C, et al. Bilateral EK rejection after COVID-19 vaccine. Eye Contact Lens. 2021;47:625–8. - PubMed
    1. Menni C, Klaser K, May A, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021;21:939–49. - PMC - PubMed
    1. Ramasamy MN, Minassian AM, Ewer KJ, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. 2021;396:1979–93. - PMC - PubMed

Substances